NCT05267522

Brief Summary

This study will comprise a randomized controlled, counter-balanced, cross-over trial to evaluate the independent effects of a high cholesterol (high egg), low saturated fat diet and a high saturated fat, low cholesterol diet on blood lipids. Evaluations also include analysis of physical activity as there is emerging evidence that the lutein and zeaxanthin in egg yolk may increase physical activity levels by crossing the blood-brain barrier and altering neuronal function. The study will also investigate effects on a number of novel lipoprotein parameters (particle size and particle concentrations).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
77

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 2, 2022

Completed
27 days until next milestone

Study Start

First participant enrolled

March 1, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 4, 2022

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 10, 2023

Completed
21 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2023

Completed
Last Updated

December 13, 2023

Status Verified

March 1, 2022

Enrollment Period

1.4 years

First QC Date

February 2, 2022

Last Update Submit

December 11, 2023

Conditions

Keywords

CholesterolEggsSaturated FatLow density lipoprotein cholesterolluteinphysical activity

Outcome Measures

Primary Outcomes (4)

  • Low-density lipoprotein cholesterol (LDL-C)

    Plasma LDL-C levels (mmol/L)

    Baseline

  • Low-density lipoprotein cholesterol (LDL-C)

    Plasma LDL-C levels (mmol/L)

    5 weeks

  • Low-density lipoprotein cholesterol (LDL-C)

    Plasma LDL-C levels (mmol/L)

    10 weeks

  • Low-density lipoprotein cholesterol (LDL-C)

    Plasma LDL-C levels (mmol/L)

    15 weeks

Secondary Outcomes (44)

  • Blood lipid profiling

    Baseline

  • Blood lipid profiling

    5 weeks

  • Blood lipid profiling

    10 weeks

  • Blood lipid profiling

    15 weeks

  • Fasting glucose

    Baseline

  • +39 more secondary outcomes

Study Arms (3)

Egg Diet

EXPERIMENTAL

Egg diet, contains 2 eggs per day and limits saturated fat to 6% of energy intake. Cholesterol intake is 600mg/day. Protein and carbohydrate levels will be maintained at 20% and 40% of energy intake, respectively. This diet will be followed for 5 weeks.

Other: Egg diet

Egg-free Diet

ACTIVE COMPARATOR

Egg-free diet, limits cholesterol to 300 mg/day (no eggs) with saturated fat intake at 12% of energy intake. Protein and carbohydrate levels will be maintained at 25% and 40% of energy intake, respectively. This diet will be followed for 5 weeks.

Other: Egg-free Diet

Control Diet

ACTIVE COMPARATOR

Comparator diet based on the average Australian diet, limited to 1 egg per week, with saturated fat intake at 12% of energy intake. Cholesterol intake is 600 mg/day. Protein and carbohydrate levels will be maintained at 25% and 40% of energy intake, respectively. This diet will be followed for 5 weeks.

Other: Control Diet

Interventions

30% fat \[6% saturated fat\], 20% protein, 40% carbohydrate, 600 mg cholesterol

Also known as: High cholesterol + low saturated fat diet
Egg Diet

30% fat \[12% saturated fat\], 25% protein, 40% carbohydrate, 300 mg cholesterol

Also known as: Low cholesterol + high saturated fat diet
Egg-free Diet

30% fat \[12% saturated fat\], 25% protein, 40% carbohydrate, 600 mg cholesterol

Also known as: Average Australian Diet
Control Diet

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male or female, aged 18 - 60 years
  • Blood LDL-C \<3.5 mmol/L (measured at screening using an automated analyser (Cholestech LDX System).
  • Non-smoker (or other nicotine products) (minimum 6 months).

You may not qualify if:

  • Have diagnosed cardiovascular disease (including uncontrolled high blood pressure) or a chronic disease, including Type-1 or -2 diabetes, kidney or liver disease, gastrointestinal disorders requiring medical nutrition therapy (e.g., Crohn's disease, irritable bowel, coeliac disease) or any other condition that may have an impact on study outcomes.
  • Have allergies or strong aversion to eggs or other components of the test foods (diets are not suitable for vegetarians).
  • Consume more than 5 eggs per week in the month prior to beginning the trial.
  • Participant has a recent history (within 12 months) or strong potential for alcohol abuse. Defined as \>14 standard drinks per week.
  • Have changed medication or supplementation that might affect study outcomes in the last 3 months.
  • Take vitamin, mineral, herbal supplementation, or medications that may have an impact on study outcomes.
  • Are already involved in another research project within 30 days of commencement of the present study that in the opinion of the investigators will be unsuitable for this study.
  • Are pregnant or breastfeeding.
  • Show unwillingness to be randomized to either experimental group.
  • Failure to satisfy the investigator regarding suitability to participate for any other reason.
  • Are unwilling or unable to provide written informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of South Australia Clinical Trial Facility

Adelaide, South Australia, 5000, Australia

Location

Related Publications (2)

  • Carter S, Hill AM, Yandell C, Wood L, Coates AM, Buckley JD. Impact of dietary cholesterol from eggs and saturated fat on LDL cholesterol levels: a randomized cross-over study. Am J Clin Nutr. 2025 Jul;122(1):83-91. doi: 10.1016/j.ajcnut.2025.05.001. Epub 2025 May 6.

  • Carter S, Hill AM, Yandell C, Buckley JD, Coates AM. Study protocol for a 15-week randomised controlled trial assessing the independent effects of high-cholesterol and high-saturated fat diets on LDL cholesterol. BMJ Open. 2024 Jan 25;14(1):e081664. doi: 10.1136/bmjopen-2023-081664.

MeSH Terms

Conditions

HypercholesterolemiaHyperlipidemiasSedentary BehaviorMotor Activity

Condition Hierarchy (Ancestors)

DyslipidemiasLipid Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesBehavior

Study Officials

  • Jonathan D Buckley, PhD

    University of South Australia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
It will not be possible to blind participants to the diet being consumed, or the research dietician assisting the participants to comply with the diets. All other research staff involved in data collection will be blinded.
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Counter-balanced, cross-over trial with randomization to the starting diet will be via minimization, based on the LDL-C concentration at screening and sex. Minimization will ensure balanced LDL-C and sex between the treatment groups at commencement of each of the three diets.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dean of Programs (Human Performance)

Study Record Dates

First Submitted

February 2, 2022

First Posted

March 4, 2022

Study Start

March 1, 2022

Primary Completion

August 10, 2023

Study Completion

August 31, 2023

Last Updated

December 13, 2023

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations